Bacillus polyfermenticus SCD의 병원성 세균에 대한 항균성과 동물 및 임상에 미치는 영향

Antibacterial Activities of B. polyfermenticus SCD Against Pathogenic Bacteria and Effects on Animals and Humans

Bacillus polyfermenticus SCD which is commonly called as Bisroot(R) has been appropriately used for the treatment of long-term intestinal disorders. This strain strongly inhibited against methicillin resistance Staphylococcus aureus (MRSA) and various pathogenic microorganisms. Effects of B. polyfermenticus SCD administration on death rates and egg-laylng rates in two groups of hens were investigated. This strain decreased the death rates of two groups by 16.26% and 11.72%, respectively. Also this strain increased the egg-laying rates of those 2.74% and 2.66%, respectively. Clinical tests of B. polyfermenticus SCD administration to healthy adults showed not adverse effects but decreased glyceride concentration from 154.52 mg/dl to 135.41 mg/dl after two week administrations.